InvestorsHub Logo

AVII77

01/16/17 10:06 AM

#95939 RE: Evaluate #95878

1. A table in the protocol. But it shouldn't be a suprize because it is consistent with FDA guidance (see the appendix of the guidance doc: endpoints for the approval of cancer drugs and biologics

2. In part, yes.